Literature DB >> 29335843

Study on the Clinical Features and Prognosis of Penicilliosis marneffei Without Human Immunodeficiency Virus Infection.

Ying-Ge Wang1, Jin-Mei Cheng1, Hai-Bo Ding2, Xi Lin1, Guo-Hao Chen1, Mei Zhou3, Sheng-Nan Ye4.   

Abstract

OBJECTIVE: To improve the diagnosis and treatment of Penicilliosis marneffei without human immunodeficiency virus infection.
METHODS: Analyze and review the clinical features, diagnosis and treatment of six cases of P. marneffei without human immunodeficiency virus infection at The First Affiliated Hospital of Fujian Medical University.
RESULTS: Two cases were diagnosed in the ENT Department, three cases in the respiratory department and one case in the dermatological department. Penicillium marneffei infection was confirmed by sputum culture, blood culture and tissue biopsy. After definite diagnosis, one refused further treatment, and others showed significant improvement.
CONCLUSION: Penicilliosis marneffei is insidious onset and easy to be escaped and misdiagnosed. To achieve early diagnosis and appropriate treatment, doubtful cases should be alerted for the diagnoses as P. marneffei.

Entities:  

Keywords:  Antimycotic chemotherapy; Penicilliosis marneffei; Penicillium marneffei; Pneumocystis pneumonia

Mesh:

Year:  2018        PMID: 29335843     DOI: 10.1007/s11046-017-0236-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  10 in total

Review 1.  Penicillium marneffei: an insurgent species among the penicillia.

Authors:  C R Cooper; N G Haycocks
Journal:  J Eukaryot Microbiol       Date:  2000 Jan-Feb       Impact factor: 3.346

2.  Fifteen cases of penicilliosis in Guangdong, China.

Authors:  Xi Liyan; Lu Changming; Zhou Xianyi; Wang Luxia; Xie Suisheng
Journal:  Mycopathologia       Date:  2004-08       Impact factor: 2.574

Review 3.  Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects.

Authors:  Nongnuch Vanittanakom; Chester R Cooper; Matthew C Fisher; Thira Sirisanthana
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 4.  Disseminated Penicillium marneffei infection in HIV-infected subject.

Authors:  W M Tsui; K F Ma; D N Tsang
Journal:  Histopathology       Date:  1992-04       Impact factor: 5.087

5.  Discontinuation of primary prophylaxis for Pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study.

Authors:  C Mussini; P Pezzotti; A Govoni; V Borghi; A Antinori; A d'Arminio Monforte; A De Luca; N Mongiardo; M C Cerri; F Chiodo; E Concia; L Bonazzi; M Moroni; L Ortona; R Esposito; A Cossarizza; B De Rienzo
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

Review 6.  [Infection of Penicillium marneffei].

Authors:  Zhao-Hui Lu; Hong-Rui Liu; Xiu-Li Xie; Ai-Xia Wang; Tong-Hua Liu
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2004-12

7.  Penicillium marneffei--an indicator disease of AIDS: a case report.

Authors:  Khuraijam Ranjana Devi; Laishram Rajesh Singh; Rita Rajkumari; M Usharani; Kh Sulochana Devi; Th Bhimo Singh
Journal:  Indian J Pathol Microbiol       Date:  2007-07       Impact factor: 0.740

8.  Penicillium marneffei infection: an emerging disease in mainland China.

Authors:  Yongxuan Hu; Junmin Zhang; Xiqing Li; Yabo Yang; Yong Zhang; Jianchi Ma; Liyan Xi
Journal:  Mycopathologia       Date:  2012-09-17       Impact factor: 2.574

9.  Clinical and laboratory characteristics of penicilliosis marneffei among patients with and without HIV infection in Northern Thailand: a retrospective study.

Authors:  Rathakarn Kawila; Romanee Chaiwarith; Khuanchai Supparatpinyo
Journal:  BMC Infect Dis       Date:  2013-10-05       Impact factor: 3.090

10.  Differences in clinical characteristics and prognosis of Penicilliosis among HIV-negative patients with or without underlying disease in Southern China: a retrospective study.

Authors:  Ye Qiu; Haifei Liao; Jianquan Zhang; Xiaoning Zhong; Caimei Tan; Decheng Lu
Journal:  BMC Infect Dis       Date:  2015-11-16       Impact factor: 3.090

  10 in total
  6 in total

1.  Sixty Years from Segretain's Description: What Have We Learned and Should Learn About the Basic Mycology of Talaromyces marneffei?

Authors:  Chi-Ching Tsang; Susanna K P Lau; Patrick C Y Woo
Journal:  Mycopathologia       Date:  2019-12       Impact factor: 2.574

2.  Case Report: Metagenomic Next-Generation Sequencing in Diagnosis of Talaromycosis of an Immunocompetent Patient.

Authors:  Jiejun Shi; Naibin Yang; Guoqing Qian
Journal:  Front Med (Lausanne)       Date:  2021-03-29

3.  Coinfection by Talaromyces marneffei and Mycobacterium abscessus in a human immunodeficiency virus-negative patient with anti-interferon-γ autoantibody: a case report.

Authors:  Weizhong Jin; Jianhong Liu; Kuang Chen; Ling Shen; Yan Zhou; Limin Wang
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

4.  MALDI-TOF MS-Based Clustering and Antifungal Susceptibility Tests of Talaromyces marneffei Isolates from Fujian and Guangxi (China).

Authors:  Lili Fang; Minxue Liu; Chunlan Huang; Jian Guo; Xiaobo Ma; Yanqing Zheng; Wenjuan Wu; Jiangshan Huang; Heping Xu
Journal:  Infect Drug Resist       Date:  2022-07-01       Impact factor: 4.177

Review 5.  Re-drawing the Maps for Endemic Mycoses.

Authors:  Nida Ashraf; Ryan C Kubat; Victoria Poplin; Antoine A Adenis; David W Denning; Laura Wright; Orion McCotter; Ilan S Schwartz; Brendan R Jackson; Tom Chiller; Nathan C Bahr
Journal:  Mycopathologia       Date:  2020-02-10       Impact factor: 2.574

Review 6.  Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis.

Authors:  Shanti Narayanasamy; John Dougherty; H Rogier van Doorn; Thuy Le
Journal:  Mycopathologia       Date:  2021-07-06       Impact factor: 2.574

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.